January 14, 2016 6:20am

 

The fact that the stem, cell and gene therapy RegMed sector has erased gains and couldn’t rally from deeply oversold conditions tells you everything you need to know about this universe

 

If it is vigilance, investors need – find it here, the time has come to SUBSCRIBE!  Can you afford not to?


Members only. Please login.